<code id='FF2AF02CC6'></code><style id='FF2AF02CC6'></style>
    • <acronym id='FF2AF02CC6'></acronym>
      <center id='FF2AF02CC6'><center id='FF2AF02CC6'><tfoot id='FF2AF02CC6'></tfoot></center><abbr id='FF2AF02CC6'><dir id='FF2AF02CC6'><tfoot id='FF2AF02CC6'></tfoot><noframes id='FF2AF02CC6'>

    • <optgroup id='FF2AF02CC6'><strike id='FF2AF02CC6'><sup id='FF2AF02CC6'></sup></strike><code id='FF2AF02CC6'></code></optgroup>
        1. <b id='FF2AF02CC6'><label id='FF2AF02CC6'><select id='FF2AF02CC6'><dt id='FF2AF02CC6'><span id='FF2AF02CC6'></span></dt></select></label></b><u id='FF2AF02CC6'></u>
          <i id='FF2AF02CC6'><strike id='FF2AF02CC6'><tt id='FF2AF02CC6'><pre id='FF2AF02CC6'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:69
          Grail

          Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

          A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

          advertisement

          The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Walmart eyes Medicare Advantage provider ChenMed
          Walmart eyes Medicare Advantage provider ChenMed

          Walmartseemspoisedtoincreaseitshealthcarefootprintbybuyingvalue-basedseniorcarecompanyChenMed.JoeRae

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Winning ticket for $1 billion Powerball jackpot sold in California

          1:36PowerballLotteryticketsareseenatastoreasthePowerballjackpotgrandprizegrewto$1billionafternoticke